IL37 and Alzheimer disease: Therefore, in vivo experiments with the combination of metabolomics and microbiota amplicon were conducted in this study to explore the anti-inflammatory mechanism of IL-37 for the potential treatment of AD, by focusing on the regulation of immunity through autophagy.